APO Research
Talk to an analyst

APO RESEARCH · REPORT

Iodixanol Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Iodixanol Injection Market Outlook and Growth Opportunities 2026

19 December 2025193 pages

Choose your research edition.

Industry ResearchIodixanol Injection Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Iodixanol Injection Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Iodixanol Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Iodixanol Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Iodixanol Injection Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Iodixanol Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Iodixanol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Iodixanol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Iodixanol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Iodixanol Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Iodixanol Injection market include Hengrui Medicine, BeiLu Pharma and GE Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Iodixanol Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Iodixanol Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Iodixanol Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iodixanol Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Iodixanol Injection Segment by Company

Hengrui Medicine

BeiLu Pharma

GE Healthcare

Iodixanol Injection Segment by Type

150 mg I/mL

270 mg I/mL

320 mg I/mL

Others

Iodixanol Injection Segment by Application

Hospitals

Clinics

Iodixanol Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Iodixanol Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Iodixanol Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Iodixanol Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Iodixanol Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iodixanol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Iodixanol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iodixanol Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Iodixanol Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Iodixanol Injection industry.

Chapter 3: Detailed analysis of Iodixanol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Iodixanol Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Iodixanol Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Iodixanol Injection Industry Trends Table 2. Iodixanol Injection Industry Drivers Table 3. Iodixanol Injection Industry Opportunities and Challenges Table 4. Iodixanol Injection Industry Restraints Table 5. Global Iodixanol Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Iodixanol Injection Revenue Share by Company (2021-2026) Table 7. Global Iodixanol Injection Sales Volume by Company (K L) & (2021-2026) Table 8. Global Iodixanol Injection Sales Volume Share by Company (2021-2026) Table 9. Global Iodixanol Injection Average Price (US$/L) of Company (2021-2026) Table 10. Global Iodixanol Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Iodixanol Injection Key Company Manufacturing Base & Headquarters Table 12. Global Iodixanol Injection Company, Product Type & Application Table 13. Global Iodixanol Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Iodixanol Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 150 mg I/mL Table 18. Significant Companies of 270 mg I/mL Table 19. Significant Companies of 320 mg I/mL Table 20. Significant Companies of Others Table 21. Global Iodixanol Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K L) Table 22. Global Iodixanol Injection Sales Volume by Type (2021-2026) & (K L) Table 23. Global Iodixanol Injection Sales Volume by Type (2027-2032) & (K L) Table 24. Global Iodixanol Injection Sales Volume Share by Type (2021-2026) Table 25. Global Iodixanol Injection Sales Volume Share by Type (2027-2032) Table 26. Global Iodixanol Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Iodixanol Injection Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Iodixanol Injection Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Iodixanol Injection Sales Value Share by Type (2021-2026) Table 30. Global Iodixanol Injection Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospitals Table 32. Significant Companies of Clinics Table 33. Global Iodixanol Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K L) Table 34. Global Iodixanol Injection Sales Volume by Application (2021-2026) & (K L) Table 35. Global Iodixanol Injection Sales Volume by Application (2027-2032) & (K L) Table 36. Global Iodixanol Injection Sales Volume Share by Application (2021-2026) Table 37. Global Iodixanol Injection Sales Volume Share by Application (2027-2032) Table 38. Global Iodixanol Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Iodixanol Injection Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Iodixanol Injection Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Iodixanol Injection Sales Value Share by Application (2021-2026) Table 42. Global Iodixanol Injection Sales Value Share by Application (2027-2032) Table 43. Global Iodixanol Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 44. Global Iodixanol Injection Sales by Region (2021-2026) & (K L) Table 45. Global Iodixanol Injection Sales Market Share by Region (2021-2026) Table 46. Global Iodixanol Injection Sales by Region (2027-2032) & (K L) Table 47. Global Iodixanol Injection Sales Market Share by Region (2027-2032) Table 48. Global Iodixanol Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Iodixanol Injection Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Iodixanol Injection Sales Value Share by Region (2021-2026) Table 51. Global Iodixanol Injection Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Iodixanol Injection Sales Value Share by Region (2027-2032) Table 53. Global Iodixanol Injection Market Average Price (US$/L) by Region (2021-2026) Table 54. Global Iodixanol Injection Market Average Price (US$/L) by Region (2027-2032) Table 55. Global Iodixanol Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Table 56. Global Iodixanol Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Iodixanol Injection Sales by Country (2021-2026) & (K L) Table 58. Global Iodixanol Injection Sales Market Share by Country (2021-2026) Table 59. Global Iodixanol Injection Sales by Country (2027-2032) & (K L) Table 60. Global Iodixanol Injection Sales Market Share by Country (2027-2032) Table 61. Global Iodixanol Injection Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Iodixanol Injection Sales Value Market Share by Country (2021-2026) Table 63. Global Iodixanol Injection Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Iodixanol Injection Sales Value Market Share by Country (2027-2032) Table 65. Hengrui Medicine Company Information Table 66. Hengrui Medicine Business Overview Table 67. Hengrui Medicine Iodixanol Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 68. Hengrui Medicine Iodixanol Injection Product Portfolio Table 69. Hengrui Medicine Recent Development Table 70. BeiLu Pharma Company Information Table 71. BeiLu Pharma Business Overview Table 72. BeiLu Pharma Iodixanol Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 73. BeiLu Pharma Iodixanol Injection Product Portfolio Table 74. BeiLu Pharma Recent Development Table 75. GE Healthcare Company Information Table 76. GE Healthcare Business Overview Table 77. GE Healthcare Iodixanol Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 78. GE Healthcare Iodixanol Injection Product Portfolio Table 79. GE Healthcare Recent Development Table 80. Key Raw Materials Table 81. Raw Materials Key Suppliers Table 82. Iodixanol Injection Distributors List Table 83. Iodixanol Injection Customers List Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Iodixanol Injection Product Image Figure 2. Global Iodixanol Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iodixanol Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Iodixanol Injection Sales (2021-2032) & (K L) Figure 5. Global Iodixanol Injection Sales Average Price (US$/L) & (2021-2032) Figure 6. Global Iodixanol Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 150 mg I/mL Image Figure 10. 270 mg I/mL Image Figure 11. 320 mg I/mL Image Figure 12. Others Image Figure 13. Global Iodixanol Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K L) Figure 14. Global Iodixanol Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Iodixanol Injection Sales Volume Share by Type (2021-2032) Figure 16. Global Iodixanol Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Iodixanol Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Iodixanol Injection Sales Value Share by Type (2021-2032) Figure 19. Hospitals Image Figure 20. Clinics Image Figure 21. Global Iodixanol Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K L) Figure 22. Global Iodixanol Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Iodixanol Injection Sales Volume Share by Application (2021-2032) Figure 24. Global Iodixanol Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Iodixanol Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Iodixanol Injection Sales Value Share by Application (2021-2032) Figure 27. Global Iodixanol Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Figure 28. Global Iodixanol Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Iodixanol Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Iodixanol Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Iodixanol Injection Sales Value (2021-2032) & (US$ Million) Figure 32. North America Iodixanol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Iodixanol Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Iodixanol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Iodixanol Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Iodixanol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Iodixanol Injection Sales Value (2021-2032) & (US$ Million) Figure 38. South America Iodixanol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Iodixanol Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Iodixanol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Iodixanol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Iodixanol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Iodixanol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iodixanol Injection Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Iodixanol Injection Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 150 mg I/mL
  • 270 mg I/mL
  • 320 mg I/mL
  • Others
Applications
  • Hospitals
  • Clinics
Companies covered
  • Hengrui Medicine
  • BeiLu Pharma
  • GE Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Iodixanol Injection Sales Value (2021-2032)
  4. 1.2.2 Global Iodixanol Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Iodixanol Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Iodixanol Injection Market Dynamics
  1. 2.1 Iodixanol Injection Industry Trends
  2. 2.2 Iodixanol Injection Industry Drivers
  3. 2.3 Iodixanol Injection Industry Opportunities and Challenges
  4. 2.4 Iodixanol Injection Industry Restraints
3 Iodixanol Injection Market by Company
  1. 3.1 Global Iodixanol Injection Company Revenue Ranking in 2025
  2. 3.2 Global Iodixanol Injection Revenue by Company (2021-2026)
  3. 3.3 Global Iodixanol Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Iodixanol Injection Average Price by Company (2021-2026)
  5. 3.5 Global Iodixanol Injection Company Ranking (2024-2026)
  6. 3.6 Global Iodixanol Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Iodixanol Injection Company Product Type and Application
  8. 3.8 Global Iodixanol Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Iodixanol Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Iodixanol Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Iodixanol Injection Market by Type
  1. 4.1 Iodixanol Injection Type Introduction
  2. 4.1.1 150 mg I/mL
  3. 4.1.2 270 mg I/mL
  4. 4.1.3 320 mg I/mL
  5. 4.1.4 Others
  6. 4.2 Global Iodixanol Injection Sales Volume by Type
  7. 4.2.1 Global Iodixanol Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Iodixanol Injection Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Iodixanol Injection Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Iodixanol Injection Sales Value by Type
  11. 4.3.1 Global Iodixanol Injection Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Iodixanol Injection Sales Value by Type (2021-2032)
  13. 4.3.3 Global Iodixanol Injection Sales Value Share by Type (2021-2032)
5 Iodixanol Injection Market by Application
  1. 5.1 Iodixanol Injection Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Iodixanol Injection Sales Volume by Application
  5. 5.2.1 Global Iodixanol Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Iodixanol Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Iodixanol Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Iodixanol Injection Sales Value by Application
  9. 5.3.1 Global Iodixanol Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Iodixanol Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Iodixanol Injection Sales Value Share by Application (2021-2032)
6 Iodixanol Injection Regional Sales and Value Analysis
  1. 6.1 Global Iodixanol Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Iodixanol Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Iodixanol Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Iodixanol Injection Sales by Region (2027-2032)
  5. 6.3 Global Iodixanol Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Iodixanol Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Iodixanol Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Iodixanol Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Iodixanol Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Iodixanol Injection Sales Value (2021-2032)
  12. 6.6.2 North America Iodixanol Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Iodixanol Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Iodixanol Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Iodixanol Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Iodixanol Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Iodixanol Injection Sales Value (2021-2032)
  21. 6.9.2 South America Iodixanol Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Iodixanol Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Iodixanol Injection Sales Value Share by Country, 2025 VS 2032
7 Iodixanol Injection Country-level Sales and Value Analysis
  1. 7.1 Global Iodixanol Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Iodixanol Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Iodixanol Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Iodixanol Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Iodixanol Injection Sales by Country (2027-2032)
  6. 7.4 Global Iodixanol Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Iodixanol Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Iodixanol Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Iodixanol Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Iodixanol Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Iodixanol Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Iodixanol Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Iodixanol Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Iodixanol Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Iodixanol Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Iodixanol Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Iodixanol Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Iodixanol Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Iodixanol Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Iodixanol Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Iodixanol Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Iodixanol Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Iodixanol Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Iodixanol Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Iodixanol Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Iodixanol Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Iodixanol Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Iodixanol Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Iodixanol Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Iodixanol Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Iodixanol Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Iodixanol Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Iodixanol Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Iodixanol Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Iodixanol Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Iodixanol Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Iodixanol Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Iodixanol Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hengrui Medicine
  2. 8.1.1 Hengrui Medicine Company Information
  3. 8.1.2 Hengrui Medicine Business Overview
  4. 8.1.3 Hengrui Medicine Iodixanol Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Hengrui Medicine Iodixanol Injection Product Portfolio
  6. 8.1.5 Hengrui Medicine Recent Developments
  7. 8.2 BeiLu Pharma
  8. 8.2.1 BeiLu Pharma Company Information
  9. 8.2.2 BeiLu Pharma Business Overview
  10. 8.2.3 BeiLu Pharma Iodixanol Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BeiLu Pharma Iodixanol Injection Product Portfolio
  12. 8.2.5 BeiLu Pharma Recent Developments
  13. 8.3 GE Healthcare
  14. 8.3.1 GE Healthcare Company Information
  15. 8.3.2 GE Healthcare Business Overview
  16. 8.3.3 GE Healthcare Iodixanol Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GE Healthcare Iodixanol Injection Product Portfolio
  18. 8.3.5 GE Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Iodixanol Injection Value Chain Analysis
  2. 9.1.1 Iodixanol Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Iodixanol Injection Sales Mode & Process
  6. 9.2 Iodixanol Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Iodixanol Injection Distributors
  9. 9.2.3 Iodixanol Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst